This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Reiffel, J. A. Articles by Blitzer, M. Search for Related Content PubMed Articles by Reiffel, J. A. Articles by Blitzer, M. Social Bookmarking                         What's this?

The Actions of Ibutilide and Class Ic Drugs on the Slow Sodium Channel: New Insights Regarding Individual Pharmacologic Effects Elucidated Through Combination Therapies

Electrophysiology Service, Cardiology Division, Department of Medicine. Columbia University College of Physicians & Surgeons, The New York Presbyterian Hospital, New York, New York

Mark Blitzer

Electrophysiology Service, Cardiology Division, Department of Medicine. Columbia University College of Physicians & Surgeons, The New York Presbyterian Hospital, New York, New York

Background: Ibutilide (I) has been reported to block I_k and to delay inactivation of the slow Na⁺ current (S-Na). There is debate about the clinical importance of the latter. Class Ic drugs block the fast Na⁺ channel, but their effect on S-Na is uncertain. If Ic treatment before infusion lessened the QT increase with I, this result would suggest both an Ic effect on S-Na and significant S-Na actions of I.

Methods: We infused I, 2 mg over 30 minutes, to 6 patients pretreated with propafenone (n = 5) or flecainide (n = 1) (group 1) and compared their increase with the QT increase seen with I alone in a combined group of 85 patients from our lab and the multicenter I database (group 2).

Results: The QTc increased in group 2, 65 ms, from 413 to 478 ms. This effect was attenuated by 47% in group 1 patients to 34 ms (P < .01). There appeared to be a dose-response relationship between Ic dose and its effects on QTc prolongation. The lowest dose of propafe none had minimal effect on the increase in QTc with I (72 ms), while higher doses of propafenone and high doses of flecainide attenuated the increase to 13 to 39 ms. Nonetheless, ibutilide efficacy was not changed, possibly suggesting differing importance of K⁺ channel and slow sodium-channel effects in atrial versus ventricular tissues, and having implications for means to reduce some antiarrhythmic drug proarrhythmia without reducing efficacy.

Conclusions: (1) Pretreatment with Ic agents can reduce the increase in QTc seen with I; (2) I's effect in humans appears to be at least partly mediated through the delay of S-Na inactivation; and (3) Ic agents probably inhibit S-Na.

Key Words: ibutilide • class III antiarrhythmic drugs • atrial fibrillation • cardioversion.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 5, No. 3, 177-181 (2000)
DOI: 10.1054/JCPT.2000.8690


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J.#x.;n. Farré, H. J.J. Wellens, J.#x. M. Rubio, and J. Benezet CHAPTER 28 Supraventricular Tachycardias ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]